ASX - By Stock
|
MSB |
Re:
CEO Itescu needs to go
|
|
Aplin
|
909 |
293K |
16 |
07/08/23 |
07/08/23 |
ASX - By Stock
|
909
|
293K
|
16
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Aplin
|
10K |
3.2M |
8 |
03/06/23 |
03/06/23 |
ASX - By Stock
|
10K
|
3.2M
|
8
|
|
Charts
|
MSB |
Re:
MSB - Chart
|
|
Aplin
|
248 |
106K |
9 |
29/05/23 |
29/05/23 |
Charts
|
248
|
106K
|
9
|
|
ASX - By Stock
|
MSB |
Re:
2023 The Final Countdown
|
|
Aplin
|
3.4K |
1.2M |
17 |
10/04/23 |
10/04/23 |
ASX - By Stock
|
3.4K
|
1.2M
|
17
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Aplin
|
10K |
3.2M |
1 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
10K
|
3.2M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Aplin
|
10K |
3.2M |
2 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
10K
|
3.2M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Aplin
|
18K |
6.9M |
8 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
18K
|
6.9M
|
8
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Schedules GvHD Pre-License Manufacturing Inspection
|
|
Aplin
|
275 |
113K |
7 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
275
|
113K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Aplin
|
18K |
6.9M |
18 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
18K
|
6.9M
|
18
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
Aplin
|
18K |
6.9M |
24 |
21/03/23 |
21/03/23 |
ASX - By Stock
|
18K
|
6.9M
|
24
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Aplin
|
10K |
3.2M |
2 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
10K
|
3.2M
|
2
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Aplin
|
10K |
3.2M |
5 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
10K
|
3.2M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
banter and General Discussion
|
|
Aplin
|
10K |
3.2M |
5 |
14/03/23 |
14/03/23 |
ASX - By Stock
|
10K
|
3.2M
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Aplin
|
1.0K |
397K |
35 |
11/03/23 |
11/03/23 |
ASX - By Stock
|
1.0K
|
397K
|
35
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
Aplin
|
1.0K |
397K |
13 |
09/03/23 |
09/03/23 |
ASX - By Stock
|
1.0K
|
397K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
HF-MACE and P3 ( dyor )
|
|
Aplin
|
16 |
6.8K |
11 |
02/03/17 |
02/03/17 |
ASX - By Stock
|
16
|
6.8K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
If the science is false, why isn't it being challenged?
|
|
Aplin
|
93 |
29K |
7 |
01/03/17 |
01/03/17 |
ASX - By Stock
|
93
|
29K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
If the science is false, why isn't it being challenged?
|
|
Aplin
|
93 |
29K |
13 |
01/03/17 |
01/03/17 |
ASX - By Stock
|
93
|
29K
|
13
|
|
ASX - By Stock
|
MSB |
Re:
If the science is false, why isn't it being challenged?
|
|
Aplin
|
93 |
29K |
1 |
01/03/17 |
01/03/17 |
ASX - By Stock
|
93
|
29K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
If the science is false, why isn't it being challenged?
|
|
Aplin
|
93 |
29K |
12 |
01/03/17 |
01/03/17 |
ASX - By Stock
|
93
|
29K
|
12
|
|